ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Kyntra Bio clinical trials

Also known as FibroGen.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 41 studies whose lead sponsor is Kyntra Bio. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 17, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Kyntra Bio with Qilu Pharmaceutical and Biocad →

Pipeline: 2 programs

Each counted once: 2 with a study Kyntra Bio leads registered in the last two years.

  • Phase 2
  • Phase 4 (approved, new studies)

The 2 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Kyntra Bio’s own registered studies; Kyntra Bio’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Kyntra Bio’s studies test, most open studies first — 3 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

All 41 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now25%Not yet recruiting 1 · Recruiting 1
  • Completed2868%
  • Stopped early1127%Terminated 10 · Withdrawn 1

Phase

  • Phase 218
  • Phase 317
  • Phase 17
  • Phase 41

Where

  • United States31
  • China12
  • Australia6
  • Korea, Republic of6
  • France5
  • Italy5

Over the years

  1. 08
  2. 09
  3. 10
  4. 11
  5. 12
  6. 13
  7. 14
  8. 15
  9. 16
  10. 17
  11. 18
  12. 19
  13. 520
  14. 21
  15. 22
  16. 23
  17. 24
  18. 25
  19. 126

By the year each study started; 4 started before 2008. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Kyntra Bio.

  • FibroGen
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    39 studies
  • Kyntra Bio
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies

Focus areas

Conditions Kyntra Bio leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 41 of 41.